Skip to main content
Explore URMC

URMC Logo

menu

Charles W. Francis, M.D.

Cancer

Publications

Showing all 302 journal articles & 17 books available

Journal Articles

5/2017
Oskarsdóttir AR, Gudmundsdottir BR, Indridason OS, Lund SH, Arnar DO, Bjornsson ES, Magnusson MK, Jensdottir HM, Vidarsson B, Francis CW, Onundarson PT. "Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial." Journal of thrombosis and thrombolysis.. 2017 May 0; 43(4):550-561.

7/1/2016
Key NS, Khorana AA, Mackman N, McCarty OJ, White GC, Francis CW, McCrae KR, Palumbo JS, Raskob GE, Chan AT, Sood AK. "Thrombosis in Cancer: Research Priorities Identified by a National Cancer Institute/National Heart, Lung, and Blood Institute Strategic Working Group." Cancer research.. 2016 Jul 1; 76(13):3671-5. Epub 2016 Jun 20.

7/2016
Kuderer NM, Culakova E, Lyman GH, Francis C, Falanga A, Khorana AA. "A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality." The oncologist.. 2016 Jul 0; 21(7):861-7. Epub 2016 Apr 28.

5/2016
Letertre LR, Gudmundsdottir BR, Francis CW, Gosselin RC, Skeppholm M, Malmstrom RE, Moll S, Hawes E, Francart S, Onundarson PT. "A single test to assay warfarin, dabigatran, rivaroxaban, apixaban, unfractionated heparin, and enoxaparin in plasma." Journal of thrombosis and haemostasis : JTH.. 2016 May 0; 14(5):1043-53. Epub 2016 Mar 30.

5/2016
Onundarson PT, Arnar DO, Lund SH, Gudmundsdottir BR, Francis CW, Indridason OS. "Fiix-prothrombin time monitoring improves warfarin anticoagulation outcome in atrial fibrillation: a systematic review of randomized trials comparing Fiix-warfarin or direct oral anticoagulants to standard PT-warfarin." International journal of laboratory hematology.. 2016 May 0; 38 Suppl 1:78-90.

4/2016
Zaffuto BJ, Conley GW, Connolly GC, Henrichs KF, Francis CW, Heal JM, Blumberg N, Refaai MA. "ABO-immune complex formation and impact on platelet function, red cell structural integrity and haemostasis: an in vitro model of ABO non-identical transfusion." Vox sanguinis.. 2016 Apr 0; 110(3):219-26. Epub 2015 Nov 03.

11/2016
Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, Hernandez AF, Gibson CM, . "Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients." The New England journal of medicine.. 2016 375(6):534-44. Epub 2016 May 27.

7/2015
White GC, Francis CW. "Victor J. Marder, M.D.: physician, scientist, founder, lover of the arts, teacher, leader (1934-2015)." Journal of thrombosis and haemostasis : JTH.. 2015 Jul 0; 13(7):1354-7. Epub 2015 Jun 11.

6/2015
Francis CW, Kessler CM, Goldhaber SZ, Kovacs MJ, Monreal M, Huisman MV, Bergqvist D, Turpie AG, Ortel TL, Spyropoulos AC, Pabinger I, Kakkar AK. "Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study." Journal of thrombosis and haemostasis : JTH.. 2015 Jun 0; 13(6):1028-35. Epub 2015 May 10.

6/2015
Onundarson PT, Francis CW, Indridason OS, Arnar DO, Bjornsson ES, Magnusson MK, Juliusson SJ, Jensdottir HM, Vidarsson B, Gunnarsson PS, Lund SH, Gudmundsdottir BR. "Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial." The Lancet. Haematology.. 2015 Jun 0; 2(6):e231-40. Epub 2015 May 25.

2/20/2015
Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Somerfield MR, Falanga A. "Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2015 Feb 20; 33(6):654-6. Epub 2015 Jan 20.

2015
A. Moss, C. Francis. "Improving Clinical Practice Guidelines for Practicing Cardiologists". American Journal of Cardiology. 2015; .

2015
B. J. Zaffuto, G. W. Conley, G. C. Connolly, K. F. Henrichs, C. W. Francis, J. M. Heal, N. Blumberg, M. A. Refaai. ""ABO-immune complex formation and impact on platelet function, red cell structural integrity and haemostasis: an in vitro model of ABO non-identical transfusion."". VoxSanguinis The International Journal of Transfusion Medicine 2015 September 11; 1-4. 2015; : 1-4.

12/2014
Khorana AA, Rubens D, Francis CW. "Screening high-risk cancer patients for VTE: a prospective observational study." Thrombosis research.. 2014 Dec 0; 134(6):1205-7. Epub 2014 Sep 20.

6/2014
Spinelli SL, Lannan KL, Casey AE, Croasdell A, Curran TM, Henrichs KF, Pollock SJ, Milne GA, Refaai MA, Francis CW, Phipps RP, Blumberg N. "Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro." Transfusion.. 2014 Jun 0; 54(6):1569-79. Epub 2013 Nov 05.

6/2014
Connolly GC, Phipps RP, Francis CW. "Platelets and cancer-associated thrombosis." Seminars in oncology.. 2014 Jun 0; 41(3):302-10. Epub 2014 Apr 24.

2014
Spinelli, Sherry L; Lannan, Katie L; Casey, Ann E;Croasdell, Amanda; Curran, Timothy M; Henrichs, Kelly F; Pollock, Stephen J; Milne, Ginger A; Refaai, Majed A; Francis, Charles F; Phipps, Richard P; Blumberg, Neil. "Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro". Blood Components. 2014; 54: 1569-1579.

11/2013
Connolly GC, Menapace L, Safadjou S, Francis CW, Khorana AA. "Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients." Clinical lung cancer.. 2013 Nov 0; 14(6):713-8. Epub 2013 Jul 26.

6/10/2013
Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Prestrud AA, Falanga A. "Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2013 Jun 10; 31(17):2189-204. Epub 2013 May 13.

5/2013
Lyman, GH; Khorana, AA; Kuderer, NM; Lee, AY; Arcelus, JI; Balaban, EP; Clarke, JM; Flowers, CR; Francis,CW; Gates, LE; Kakkar, AJ; Key, NS; Levine, MN; Liebman, HA; Tempero, MA; Wong, SL; Prestrud, AA; Falanga, A. "Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Practice Guideline Update." Journal of Clinical Oncology. 2013; .

4/2013
Francis CW. "Prevention of VTE in patients having major orthopedic surgery." Journal of thrombosis and thrombolysis.. 2013 Apr 0; 35(3):359-67.

2/2013
Refaai MA, Carter J, Henrichs KF, Davidson DC, Pollock SJ, Casey AE, Spinelli SL, Phipps RP, Francis CW, Blumberg N. "Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and -B." Transfusion.. 2013 Feb 0; 53(2):382-93. Epub 2012 May 25.

2013
Connolly, G; Menapace, L; Safadjou, S; Francis, CW; Khorana, A. "Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients." Clinical Lung cancer. 2013; : In Press.

2013
Kuderer, NM; Culakova, E; Lyman, GH; Francis, C; Falanga, A; Khorana, AA. "A Validated Risk Score for VTE is Predictive Of Early Cancer Progression and Mortality". Journal of Clinical Oncology - Submitted. 2013; .

2013
Spinelli, SL; Lannan, KL; Case, AE; Croasdell, A; Curran, TM; Henrichs, KF; Pollock, SJ; Refaai, MA; Francis, CW; Milne, GA; Phipps, RP; Blumberg, N. "Isoporstane and isofuran lipid mediators accumulate in stored red blood cell concentrates and influence platelet function in vitro". Transfusion. 2013; .

2013
Spinelli, SL; Lannan, KL; Casey, AE; Croasdell, A; Curran, TM; Henrichs, KF; Pollock, SJ; Milne, GA; Refaai, MA; Francis, CW; Phipps, P and Blumberg, N. "Isoprostane and isofuran lipid mediators accumulate in stored red blood cells and influence platelet function in vitro". Transfusion. 2013; [Epub ahead of print].

2013
Connolly GC, Francis CW. "Cancer-associated thrombosis." Hematology. 2013 2013:684-91.

10/2012
Gudmundsdottir BR, Francis CW, Bjornsdottir AM, Nellbring M, Onundarson PT. "Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time." Thrombosis research.. 2012 Oct 0; 130(4):674-81. Epub 2012 Jan 04.

8/2012
Hackney DN, Miller RK, Pressman EK, Francis CW, Simhan HN. "Vaginal bleeding in early pregnancy and circulating markers of thrombin generation." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.. 2012 Aug 0; 25(8):1479-82. Epub 2012 Jan 24.

7/2012
Khorana AA, Spyropoulos AC, Zwicker J, Lyman GH, Francis CW. "Preventing VTE in Outpatients With Cancer." Chest.. 2012 Jul 0; 142(1):265-266.

6/2012
Mongan J, Mieszczanska HZ, Smith BH, Messing SP, Phipps RP, Francis CW. "Pioglitazone inhibits platelet function and potentiates the effects of aspirin: a prospective observation study." Thrombosis research.. 2012 Jun 0; 129(6):760-4. Epub 2012 Jan 04.

5/2012
Ragni MV, Moore CG, Bias V, Key NS, Kouides PA, Francis CW, . "Challenges of rare disease research: limited patients and competing priorities." Haemophilia : the official journal of the World Federation of Hemophilia.. 2012 May 0; 18(3):e192-4. Epub 2011 Sep 13.

2/2012
Guyatt GH, Eikelboom JW, Gould MK, Garcia DA, Crowther M, Murad MH, Kahn SR, Falck-Ytter Y, Francis CW, Lansberg MG, Akl EA, Hirsh J. "Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines." Chest.. 2012 Feb 0; 141(2 Suppl):e185S-e194S.

2/2012
Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW. "Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines." Chest.. 2012 Feb 0; 141(2 Suppl):e278S-e325S.

7/2011
Refaai MA, Fialkow LB, Heal JM, Henrichs KF, Spinelli SL, Phipps RP, Masel E, Smith BH, Corsetti JP, Francis CW, Bankey PE, Blumberg N. "An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients." Vox sanguinis.. 2011 Jul 0; 101(1):55-60. Epub 2011 Mar 18.

3/3/2011
Moss AJ, Francis CW, Ryan D. "Collaborative clinical trials." The New England journal of medicine.. 2011 Mar 3; 364(9):789-91.

1/1/2011
Refaai MA, Henrichs KF, Spinelli SL, Phipps RP, Masel E, Smith BH, Francis CW, Blumberg N. "Platelet Activation Following Exposure to Anti-ABO Antibodies-An In Vitro Study." US oncology & hematology.. 2011 Jan 1; 7(1):72-74.

2011
Refaai, MA; Henrichs, KF; Spinelli, SL; Phipps, RP; Masel, E; Smith, BH; Francis, CW; Blumberg, N. "Platelet Activation Following Exposure to Anti-ABO Antibodies-An In Vitro Study." US Oncology & Hematology. 2011; 7(1): 72-4.

9/2010
Friedman RJ, Dahl OE, Rosencher N, Caprini JA, Kurth AA, Francis CW, Clemens A, Hantel S, Schnee JM, Eriksson BI, . "Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials." Thrombosis research.. 2010 Sep 0; 126(3):175-82. Epub 2010 May 15.

8/2010
Connolly GC, Khorana AA, Kuderer NM, Culakova E, Francis CW, Lyman GH. "Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy." Thrombosis research.. 2010 Aug 0; 126(2):113-8.

7/2010
Candelario GD, Francis CW, Panzer R, McAdam KS, Cockrell D, Baird T, Khorana AA. "A computerized prompt for thromboprophylaxis in hospitalized cancer patients." Thrombosis research.. 2010 Jul 0; 126(1):32-4. Epub 2009 Oct 30.

6/5/2010
Connolly GC, Khorana AA, Kuderer NM, Culakova E, Francis CW, Lyman GH. "Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy." Thrombosis research.. 2010 Jun 5; Epub 2010 Jun 05.

6/2010
Refaai MA, Chuang C, Menegus M, Blumberg N, Francis CW. "Outcomes after platelet transfusion in patients with heparin-induced thrombocytopenia." Journal of thrombosis and haemostasis : JTH.. 2010 Jun 0; 8(6):1419-21. Epub 2010 Mar 19.

3/2010
Spinelli SL, Casey AE, Pollock SJ, Gertz JM, McMillan DH, Narasipura SD, Mody NA, King MR, Maggirwar SB, Francis CW, Taubman MB, Blumberg N, Phipps RP. "Platelets and megakaryocytes contain functional nuclear factor-kappaB." Arteriosclerosis, thrombosis, and vascular biology.. 2010 Mar 0; 30(3):591-8. Epub 2009 Dec 30.

12/2009
Blumberg N, Spinelli SL, Francis CW, Taubman MB, Phipps RP. "The platelet as an immune cell-CD40 ligand and transfusion immunomodulation." Immunologic research.. 2009 Dec 0; 45(2-3):251-60. Epub 2009 Jan 29.

11/2009
Bernard JJ, Seweryniak KE, Koniski AD, Spinelli SL, Blumberg N, Francis CW, Taubman MB, Palis J, Phipps RP. "Foxp3 regulates megakaryopoiesis and platelet function." Arteriosclerosis, thrombosis, and vascular biology.. 2009 Nov 0; 29(11):1874-82. Epub 2009 Aug 06.

10/10/2009
Francis CW. "Prevention of venous thromboembolism in hospitalized patients with cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2009 Oct 10; 27(29):4874-80. Epub 2009 Aug 24.

10/10/2009
Kuderer NM, Ortel TL, Francis CW. "Impact of venous thromboembolism and anticoagulation on cancer and cancer survival." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2009 Oct 10; 27(29):4902-11. Epub 2009 Sep 08.

9/2009
Brummel-Ziedins KE, Gissel M, Francis C, Queenan J, Mann KG. "The effect of high circulating estradiol levels on thrombin generation during in vitro fertilization." Thrombosis research.. 2009 Sep 0; 124(4):505-7. Epub 2009 Mar 17.

7/2009
Sandset PM, Francis C. "Thrombosis Research: Introduction of e-pages." Thrombosis research.. 2009 Jul 0; 124(3):251.

5/2009
Yao JL, Ryan CK, Francis CW, Kohli M, Taubman MB, Khorana AA. "Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study." Cancer investigation.. 2009 May 0; 27(4):430-4.

5/2009
Springer D, Miller J, Spinelli S, Pasa-Tolic L, Purvine S, Daly D, Zangar R, Jin S, Blumberg N, Francis C, Taubman M, Casey A, Wittlin S, Phipps R. "Platelet proteome changes associated with diabetes and during platelet storage for transfusion." Journal of proteome research.. 2009 May 0; 8(5):2261-72.

1/2009
, Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, Lieberman JR, Muntz JE, Raskob GE, Clements ML, Hantel S, Schnee JM, Caprini JA. "Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery." The Journal of arthroplasty.. 2009 Jan 0; 24(1):1-9. Epub 2008 Apr 14.

1/2009
O'Brien JJ, Baglole CJ, Garcia-Bates TM, Blumberg N, Francis CW, Phipps RP. "15-deoxy-Delta12,14 prostaglandin J2-induced heme oxygenase-1 in megakaryocytes regulates thrombopoiesis." Journal of thrombosis and haemostasis : JTH.. 2009 Jan 0; 7(1):182-9. Epub 2008 Oct 10.

11/24/2008
Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH. "Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer." Archives of internal medicine.. 2008 Nov 24; 168(21):2377-81.

11/15/2008
O'Brien JJ, Spinelli SL, Tober J, Blumberg N, Francis CW, Taubman MB, Palis J, Seweryniak KE, Gertz JM, Phipps RP. "15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes." Blood.. 2008 Nov 15; 112(10):4051-60. Epub 2008 Aug 28.

11/2008
Khorana AA, Francis CW, Menzies KE, Wang JG, Hyrien O, Hathcock J, Mackman N, Taubman MB. "Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer." Journal of thrombosis and haemostasis : JTH.. 2008 Nov 0; 6(11):1983-5. Epub 2008 Sep 15.

5/15/2008
Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. "Development and validation of a predictive model for chemotherapy-associated thrombosis." Blood.. 2008 May 15; 111(10):4902-7. Epub 2008 Jan 23.

1/2008
Sahni A, Simpson-Haidaris PJ, Sahni SK, Vaday GG, Francis CW. "Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2)." Journal of thrombosis and haemostasis : JTH.. 2008 Jan 0; 6(1):176-83. Epub 2007 Oct 22.

1/2008
Ray DM, Spinelli SL, Pollock SJ, Murant TI, O'Brien JJ, Blumberg N, Francis CW, Taubman MB, Phipps RP. "Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles." Thrombosis and haemostasis.. 2008 Jan 0; 99(1):86-95.

2008
O'Brien JJ; Spinelli S; Tober J; Blumberg N; Francis CW; Taubman M;. "15-deoxy-&d12, 14-PGJ2 enhances platelet production from megakaryocytes". Blood. 2008; .

2008
Ginsberg JS; Davidson BL; Comp PC; Francis CW; Friedman RJ; Hyo MH; Lieberman J; Muntz JE; Raskob GE; Clements ML; Hantel S; Schnee JM; Caprini JA for the RE-MOBILIZE Study Group. "The oral thrombin inhibitor debigatran etexilate vs the North American enoxaparin regimen for the prevention of venous thromboembolism after knee replacement surgery: the RE-MOBILIZE trial". J Arthroplasty. 2008; .

2008
Spinelli SL, O'Brien JJ, Bancos S, Lehmann GM, Springer DL, Blumberg N, Francis CW, Taubman MB, Phipps RP. "The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects." PPAR research. 2008 2008:328172.

2008
Francis CW. "Warfarin: an historical perspective." Hematology. 2008 :251.

2008
Francis CW. "New issues in oral anticoagulants." Hematology. 2008 :259-65.

12/1/2007
Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H, Mendelson D, Raskob G, Somerfield MR, Thodiyil P, Trent D, Francis CW, . "American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2007 Dec 1; 25(34):5490-505. Epub 2007 Oct 29.

11/15/2007
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. "Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients." Cancer.. 2007 Nov 15; 110(10):2339-46.

9/1/2007
Kuderer NM, Khorana AA, Lyman GH, Francis CW. "A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications." Cancer.. 2007 Sep 1; 110(5):1149-61.

5/15/2007
Khorana AA, Ahrendt SA, Ryan CK, Francis CW, Hruban RH, Hu YC, Hostetter G, Harvey J, Taubman MB. "Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2007 May 15; 13(10):2870-5.

5/2007
Mieszczanska H, Kaba NK, Francis CW, Gerich JE, Dodis R, Schwarz KQ, Phipps RP, Smith BH, Lee M, Messing S, Taubman MB. "Effects of pioglitazone on fasting and postprandial levels of lipid and hemostatic variables in overweight non-diabetic patients with coronary artery disease." Journal of thrombosis and haemostasis : JTH.. 2007 May 0; 5(5):942-9.

4/5/2007
Francis CW. "Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients." The New England journal of medicine.. 2007 Apr 5; 356(14):1438-44.

3/2007
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. "Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy." Journal of thrombosis and haemostasis : JTH.. 2007 Mar 0; 5(3):632-4.

1/2007
O'Brien JJ, Ray DM, Spinelli SL, Blumberg N, Taubman MB, Francis CW, Wittlin SD, Phipps RP. "The platelet as a therapeutic target for treating vascular diseases and the role of eicosanoid and synthetic PPARgamma ligands." Prostaglandins & other lipid mediators. 2007 Jan 0; 82(1-4):68-76. Epub 2006 Jul 10.

2007
Kuderer NM; Khorana AA; Lyman GH; Francis CW. "A Meta-Analysis and Systematic Review of the Efficacy and Safety of Anticoagulants as Cancer Treatment: Impact on survival and Bleeding Complications". Cancer. 2007; 5: 1149-1161.

6/2006
Komrokji RS, Uppal NP, Khorana AA, Lyman GH, Kaplan KL, Fisher RI, Francis CW. "Venous thromboembolism in patients with diffuse large B-cell lymphoma." Leukemia & lymphoma.. 2006 Jun 0; 47(6):1029-33.

1/20/2006
Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH. "Thromboembolism in hospitalized neutropenic cancer patients." Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2006 Jan 20; 24(3):484-90.

1/1/2006
Sahni A, Khorana AA, Baggs RB, Peng H, Francis CW. "FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis." Blood.. 2006 Jan 1; 107(1):126-31. Epub 2005 Sep 13.

2006
Khorana AA; Francis CW; Culakova E; Fisher RI; Kuderer N; Lyman GH. "Thromboembolism in hospitalized neutropenic cancer patients". J Clin Oncol. 2006; .

2006
Blumberg N; Francis CW; Heal J. "Clinical Use of Plasma and Plasma Fractions". Baillier's Best Practice & Research: Clinical Haematology. 2006; .

12/15/2005
Khorana AA, Francis CW, Culakova E, Lyman GH. "Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study." Cancer.. 2005 Dec 15; 104(12):2822-9.

10/2005
Sahni A, Sahni SK, Francis CW. "Endothelial cell activation by IL-1beta in the presence of fibrinogen requires alphavbeta3." Arteriosclerosis, thrombosis, and vascular biology.. 2005 Oct 0; 25(10):2222-7. Epub 2005 Aug 25.

10/2005
Colwell CW, Berkowitz SD, Lieberman JR, Comp PC, Ginsberg JS, Paiement G, McElhattan J, Roth AW, Francis CW, . "Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty." The Journal of bone and joint surgery. American volume.. 2005 Oct 0; 87(10):2169-77.

7/15/2005
Moss AJ, Ryan D, Oakes D, Goldstein RE, Greenberg H, Bodenheimer MM, Brown MW, Case RB, Dwyer EM, Eberly SW, Francis CW, Gillespie JA, Krone RJ, Lichstein E, MacCluer JW, Marcus FI, McCarthy J, Sparks CE, Zareba W. "Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction." The American journal of cardiology.. 2005 Jul 15; 96(2):177-82.

6/2005
Rozmus G, Daubert JP, Huang DT, Rosero S, Hall B, Francis C. "Venous thrombosis and stenosis after implantation of pacemakers and defibrillators." Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing.. 2005 Jun 0; 13(1):9-19.

2/9/2005
Fiessinger JN, Huisman MV, Davidson BL, Bounameaux H, Francis CW, Eriksson H, Lundström T, Berkowitz SD, Nyström P, Thorsén M, Ginsberg JS, . "Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial." JAMA.. 2005 Feb 9; 293(6):681-9.

2005
Sahni A; Sahni S; Francis CW. "Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires avB3." ATVB. 2005; .

2005
Fiessinger JN; Huisman MV; Davidson BL; Bounameaux H; Francis CW. "Ximelagatran vs. low molecular weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized controlled trial". JAMA. 2005; .

2005
Sahni A; Khorana AA; Baggs RB; Peng H; Francis CW. "FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis". Blood. 2005; .

2005
Francis CW. "Direct thrombin inhibitors for treatment of heparin induced thrombocytopenia, deep vein thrombosis and atrial fibrillation." Current pharmaceutical design.. 2005 11(30):3931-41.

12/1/2004
Sahni A, Francis CW. "Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires alphavbeta3." Blood.. 2004 Dec 1; 104(12):3635-41. Epub 2004 Aug 05.

10/6/2004
Siegel RJ, Suchkova VN, Miyamoto T, Luo H, Baggs RB, Neuman Y, Horzewski M, Suorsa V, Kobal S, Thompson T, Echt D, Francis CW. "Ultrasound energy improves myocardial perfusion in the presence of coronary occlusion." Journal of the American College of Cardiology.. 2004 Oct 6; 44(7):1454-8.

10/2004
Guo M, Sahni SK, Sahni A, Francis CW. "Fibrinogen regulates the expression of inflammatory chemokines through NF-kappaB activation of endothelial cells." Thrombosis and haemostasis.. 2004 Oct 0; 92(4):858-66.

9/1/2004
Akbiyik F, Ray DM, Gettings KF, Blumberg N, Francis CW, Phipps RP. "Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes." Blood.. 2004 Sep 1; 104(5):1361-8. Epub 2004 May 06.

9/2004
Sahni A, Sahni SK, Simpson-Haidaris PJ, Francis CW. "Fibrinogen binding potentiates FGF-2 but not VEGF induced expression of u-PA, u-PAR, and PAI-1 in endothelial cells." Journal of thrombosis and haemostasis : JTH.. 2004 Sep 0; 2(9):1629-36.

7/15/2004
Sahni A, Guo M, Sahni SK, Francis CW. "Interleukin-1beta but not IL-1alpha binds to fibrinogen and fibrin and has enhanced activity in the bound form." Blood.. 2004 Jul 15; 104(2):409-14. Epub 2004 Mar 23.

5/15/2004
Joshi SG, Francis CW, Silverman DJ, Sahni SK. "NF-kappaB activation suppresses host cell apoptosis during Rickettsia rickettsii infection via regulatory effects on intracellular localization or levels of apoptogenic and anti-apoptotic proteins." FEMS microbiology letters.. 2004 May 15; 234(2):333-41.

5/2004
Kaba NK, Francis CW, Moss AJ, Zareba W, Oakes D, Knox KL, Fernández ID, Rainwater DL, . "Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction." Journal of thrombosis and haemostasis : JTH.. 2004 May 0; 2(5):718-25.

4/2004
Altland OD, Dalecki D, Suchkova VN, Francis CW. "Low-intensity ultrasound increases endothelial cell nitric oxide synthase activity and nitric oxide synthesis." Journal of thrombosis and haemostasis : JTH.. 2004 Apr 0; 2(4):637-43.

3/15/2004
Peng H, Sahni A, Fay P, Bellum S, Prudovsky I, Maciag T, Francis CW. "Identification of a binding site on human FGF-2 for fibrinogen." Blood.. 2004 Mar 15; 103(6):2114-20. Epub 2003 Nov 20.

3/2004
Francis CW. "Ximelagatran: a new oral anticoagulant." Best practice & research. Clinical haematology.. 2004 Mar 0; 17(1):139-52.

2004
Francis CW; Berkowitz SD; Comp PC. "Comparison of the Oral Direct Thrombin Inhibitor Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism Following total Knee Replacement". NEJM. 2004; 349: 1703-1712.

2004
Sahni A; Guo M; Sahni SK; Francis CW. "Interluekin-1B but not IL-1a Binds t Fibrinogen and Fibrin and has Enhanced Activity in the Bound Form". Blood. 2004; .

2004
Sahni A; Sahni SK; Simpson-Haidaris PJ; Francis CW. "Fibrinogen binding potentiates FGF-2 but not VEGF induced expression of uPA, uPAR, and PAI-1 in endothelial cells." J Thromb Haemost. 2004; .

2004
Akbiyik F; Ray DM; Gettings KF; Blumberg N; Francis CW and Phipps RP;. "Human bone marrow megakaryocytes and platelets express PPARy and PPARy agonists blunt platelet release of CD40 ligand and thromboxanes". Blood. 2004; .

2004
Guo M; Sahni SK; Sahni A; Francis CW;. "Fibrinogen regulates the expression of inflammatory chemokines through NF-kB activation of endothelial cells". J Thromb Haemost. 2004; .

2004
Siegel RJ; Suchkova VN; Miyamoto T; Luo H; Baggs RB; Neuman Y; Horzewski M; Francis CW; et al. "Ultrasound Energy Improves Myocardial Perfusion in the Presence of Coronary Occlusion". JACC. 2004; .

11/1/2003
Khorana AA, Sahni A, Altland OD, Francis CW. "Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight." Arteriosclerosis, thrombosis, and vascular biology.. 2003 Nov 1; 23(11):2110-5. Epub 2003 Aug 14.

10/30/2003
Francis CW, Berkowitz SD, Comp PC, Lieberman JR, Ginsberg JS, Paiement G, Peters GR, Roth AW, McElhattan J, Colwell CW, . "Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement." The New England journal of medicine.. 2003 Oct 30; 349(18):1703-12.

10/2003
Colwell CW, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, Neubauer J, McElhattan JL, Peters GR, Francis CW. "Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study." Journal of thrombosis and haemostasis : JTH.. 2003 Oct 0; 1(10):2119-30.

7/2003
Joshi SG, Francis CW, Silverman DJ, Sahni SK. "Nuclear factor kappa B protects against host cell apoptosis during Rickettsia rickettsii infection by inhibiting activation of apical and effector caspases and maintaining mitochondrial integrity." Infection and immunity.. 2003 Jul 0; 71(7):4127-36.

6/2003
Sahni A, Francis CW. "Plasmic degradation modulates activity of fibrinogen-bound fibroblast growth factor-2." Journal of thrombosis and haemostasis : JTH.. 2003 Jun 0; 1(6):1271-7.

6/2003
Sahni A, Altland OD, Francis CW. "FGF-2 but not FGF-1 binds fibrin and supports prolonged endothelial cell growth." Journal of thrombosis and haemostasis : JTH.. 2003 Jun 0; 1(6):1304-10.

4/2003
Kaba NK, Francis CW, Hall WJ, Falsey AR, Smith BH. "Protein S declines during winter respiratory infections." Journal of thrombosis and haemostasis : JTH.. 2003 Apr 0; 1(4):729-34.

1/2003
Gottlieb RH, Voci SL, Syed L, Shyu C, Fultz PJ, Rubens DJ, Strang JG, Carson N, DiGrazio WJ, Francis CW. "Randomized prospective study comparing routine versus selective use of sonography of the complete calf in patients with suspected deep venous thrombosis." AJR. American journal of roentgenology.. 2003 Jan 0; 180(1):241-5.

2003
Joshi S; Francis CW; Silverman DJ; Sahni S. "Nuclear Factor kB protects against Host Cell Apoptosis during Rickettsia rickettsii iinfection by inhibiting activation of apical and effector caspases and maintaining mitochondrial integrity". Infection and Immunity. 2003; .

2003
Shammas NW; Pennell BJ; Rossen J; Francis CW; et al. "Evaluation of platelet activation, fibrinolysis and hemostatic activation during high dose dobutamine stress echocardiography". Journal of Angiology. 2003; 12: 162-165.

2003
Sahni A; Altland O; Francis CW. "FGF-2 but not FGF-1 binds fibrin and supports prolonged endothelial cell growth". J Thromb Hemost. 2003; 1: 1304-1310.

2003
Kaba NK; Francis CW; Hall WJ; Falsey AF; Smith BH. "Protein S declines during winter respiratory infections". J Thromb and Haemost. 2003; 1: 729-732.

2003
Colwell CW; Berkowitz SD; Davidson BL; Lotke PA; Francis CW; et al. "Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study". J Thromb Hemost. 2003; 1: 2119-2130.

2003
Colwell CW; Francis CW; Berkowitz SE; et al. "Oral direct thrombin inhibitor ximelagatran compared with warfarin for prevention of venous thromboembolism after total knee replacement". J Thromb Haemost. 2003; .

2003
Alving BM, Francis CW, Hiatt WR, Jackson MR. "Consultations on patients with venous or arterial diseases." Hematology. 2003 :540-58.

11/2002
Francis CW. "Factor XIII polymorphisms and venous thromboembolism." Archives of pathology & laboratory medicine.. 2002 Nov 0; 126(11):1391-3.

11/2002
Francis CW. "Plasminogen activator inhibitor-1 levels and polymorphisms." Archives of pathology & laboratory medicine.. 2002 Nov 0; 126(11):1401-4.

11/2002
Suchkova VN, Baggs RB, Sahni SK, Francis CW. "Ultrasound improves tissue perfusion in ischemic tissue through a nitric oxide dependent mechanism." Thrombosis and haemostasis.. 2002 Nov 0; 88(5):865-70.

10/15/2002
Francis CW, Davidson BL, Berkowitz SD, Lotke PA, Ginsberg JS, Lieberman JR, Webster AK, Whipple JP, Peters GR, Colwell CW. "Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial." Annals of internal medicine.. 2002 Oct 15; 137(8):648-55.

8/13/2002
Byrne NP, Henry JC, Herrmann DN, Abdelhalim AN, Shrier DA, Francis CW, Powers JM. "Neuropathologic findings in a Guillain-Barré patient with strokes after IVIg therapy." Neurology.. 2002 Aug 13; 59(3):458-61.

7/2002
Kaplan KL, Francis CW. "Direct thrombin inhibitors." Seminars in hematology.. 2002 Jul 0; 39(3):187-96.

3/2002
Suchkova V, Carstensen EL, Francis CW. "Ultrasound enhancement of fibrinolysis at frequencies of 27 to 100 kHz." Ultrasound in medicine & biology.. 2002 Mar 0; 28(3):377-82.

2002
Suchkova VN; Carstensen EL; Francis CW. "Ultrasound enhancement of fibrinolysis at frequencies of 27 to 100 kHz". Ultrasound in Med & Biol. 2002; 28: 377-382.

12/2001
Horan JT, Francis CW. "Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation." Seminars in thrombosis and hemostasis.. 2001 Dec 0; 27(6):657-66.

10/8/2001
Heit JA, Colwell CW, Francis CW, Ginsberg JS, Berkowitz SD, Whipple J, Peters G, . "Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study." Archives of internal medicine.. 2001 Oct 8; 161(18):2215-21.

9/10/2001
Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Ghali WA, Butcher MS, Brant RF, Bergqvist D, Hamulyák K, Francis CW, Marder VJ, Raskob GE. "Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review." Archives of internal medicine.. 2001 Sep 10; 161(16):1952-60.

5/2001
Anolik JH, Blumberg N, Snider J, Francis CW. "Posttransfusion purpura secondary to an alloantibody reactive with HPA-5a (Br(b))." Transfusion.. 2001 May 0; 41(5):633-6.

4/1/2001
Falsey AR, Walsh EE, Francis CW, Looney RJ, Kolassa JE, Hall WJ, Abraham GN. "Response of C-reactive protein and serum amyloid A to influenza A infection in older adults." The Journal of infectious diseases.. 2001 Apr 1; 183(7):995-9. Epub 2001 Feb 23.

4/2001
Francis CW. "Ultrasound-enhanced thrombolysis." Echocardiography.. 2001 Apr 0; 18(3):239-46.

2/2001
Horan JT, Francis CW, Falsey AR, Kolassa J, Smith BH, Hall WJ. "Prothrombotic changes in hemostatic parameters and C-reactive protein in the elderly with winter acute respiratory tract infections." Thrombosis and haemostasis.. 2001 Feb 0; 85(2):245-9.

2001
Falsey AR; Walsh EE; Francis CW; et al. "Response of C-reactive protein (CRP) and serum amyloid A (SAA) to influenza A infections in older adults". J Infec Dis. 2001; 183: 995-999.

2001
Hull RD; Pinieo GF; Stein PD; Mah AF; Francis CW; et al. "Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systemic review". Arch Intern Med. 2001; 16: 1852-1960.

2001
Francis CW, Suchkova VN. "Ultrasound and thrombolysis." Vascular medicine.. 2001 6(3):181-7.

12/1/2000
Sahni A, Francis CW. "Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation." Blood.. 2000 Dec 1; 96(12):3772-8.

9/12/2000
Bili A, Moss AJ, Francis CW, Zareba W, Watelet LF, Sanz I. "Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators." Circulation.. 2000 Sep 12; 102(11):1258-63.

9/2000
Everbach EC, Francis CW. "Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1 MHz." Ultrasound in medicine & biology.. 2000 Sep 0; 26(7):1153-60.

5/16/2000
Suchkova VN, Baggs RB, Francis CW. "Effect of 40-kHz ultrasound on acute thrombotic ischemia in a rabbit femoral artery thrombosis model: enhancement of thrombolysis and improvement in capillary muscle perfusion." Circulation.. 2000 May 16; 101(19):2296-301.

5/2000
Sahni A, Baker CA, Sporn LA, Francis CW. "Fibrinogen and fibrin protect fibroblast growth factor-2 from proteolytic degradation." Thrombosis and haemostasis.. 2000 May 0; 83(5):736-41.

2000
Hull R; Pineo G; Francis CW; Bergquist D; et al. "A double-blind, randomized comparison of low-molecular weight heparin prophylaxis using dalteparin extended out of hospital versus warfarin-placebo in hip-arthroplasty patients". Arch Int Med. 2000; 160: 2208-2215.

12/1999
McCarron BI, Marder VJ, Francis CW. "Reactivity of soluble fibrin assays with plasmic degradation products of fibrin and in patients receiving fibrinolytic therapy." Thrombosis and haemostasis.. 1999 Dec 0; 82(6):1722-9.

9/1999
Shortell CK, Francis CW. "Thrombolytic therapy for arterial thrombosis." Current opinion in hematology.. 1999 Sep 0; 6(5):309-13.

8/1999
Weisel JW, Veklich Y, Collet JP, Francis CW. "Structural studies of fibrinolysis by electron and light microscopy." Thrombosis and haemostasis.. 1999 Aug 0; 82(2):277-82.

7/1999
McCarron BI, Marder VJ, Kanouse JJ, Francis CW. "A soluble fibrin standard: comparable dose-response with immunologic and functional assays." Thrombosis and haemostasis.. 1999 Jul 0; 82(1):145-8.

5/21/1999
Sahni A, Sporn LA, Francis CW. "Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2." The Journal of biological chemistry.. 1999 May 21; 274(21):14936-41.

4/23/1999
Francis CW, Timpson ME, Wilson JH. "Bench- and pilot-scale studies relating to the removal of uranium from uranium-contaminated soils using carbonate and citrate lixiviants." Journal of hazardous materials.. 1999 Apr 23; 66(1-2):67-87.

3/1999
Kaplan KL, Francis CW. "Heparin-induced thrombocytopenia." Blood reviews.. 1999 Mar 0; 13(1):1-7.

1999
Francis CW; Pleil AM; Reinhart SP;. "A pharmacoeconomic evaluation of low-molecular-wweight heparin in patients after total hip-replacement surgery". P&T. 1999; 24: 136-145.

12/15/1998
Veklich Y, Francis CW, White J, Weisel JW. "Structural studies of fibrinolysis by electron microscopy." Blood.. 1998 Dec 15; 92(12):4721-9.

9/8/1998
Suchkova V, Siddiqi FN, Carstensen EL, Dalecki D, Child S, Francis CW. "Enhancement of fibrinolysis with 40-kHz ultrasound." Circulation.. 1998 Sep 8; 98(10):1030-5.

8/1998
Felcher A, Commichau C, Cao Q, Brown MJ, Torres A, Francis CW. "Disseminated intravascular coagulation and status epilepticus." Neurology.. 1998 Aug 0; 51(2):629-31.

3/27/1998
Sahni A, Odrljin T, Francis CW. "Binding of basic fibroblast growth factor to fibrinogen and fibrin." The Journal of biological chemistry.. 1998 Mar 27; 273(13):7554-9.

3/15/1998
Siddiqi F, Odrljin TM, Fay PJ, Cox C, Francis CW. "Binding of tissue-plasminogen activator to fibrin: effect of ultrasound." Blood.. 1998 Mar 15; 91(6):2019-25.

2/15/1998
Ryan DH, Crowther MA, Ginsberg JS, Francis CW. "Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery." Annals of internal medicine.. 1998 Feb 15; 128(4):270-6.

1/1998
Everbach EC, Makin IR, Francis CW, Meltzer RS. "Effect of acoustic cavitation on platelets in the presence of an echo-contrast agent." Ultrasound in medicine & biology.. 1998 Jan 0; 24(1):129-36.

9/1997
Braaten JV, Goss RA, Francis CW. "Ultrasound reversibly disaggregates fibrin fibers." Thrombosis and haemostasis.. 1997 Sep 0; 78(3):1063-8.

9/1997
Francis CW, Pellegrini VD, Totterman S, Boyd AD, Marder VJ, Liebert KM, Stulberg BN, Ayers DC, Rosenberg A, Kessler C, Johanson NA. "Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin." The Journal of bone and joint surgery. American volume.. 1997 Sep 0; 79(9):1365-72.

5/1997
Geigel EJ, Francis CW. "Reversal of multiorgan system dysfunction in sickle cell disease with plasma exchange." Acta anaesthesiologica Scandinavica.. 1997 May 0; 41(5):647-50.

4/1997
Riggs PN, Francis CW, Bartos SR, Penney DP. "Ultrasound enhancement of rabbit femoral artery thrombolysis." Cardiovascular surgery : official journal of the International Society for Cardiovascular Surgery.. 1997 Apr 0; 5(2):201-7.

2/1997
Illig KA, Green RM, Ouriel K, Riggs PN, Bartos S, Whorf R, DeWeese JA, Chhibber A, Marder VJ, Francis CW. "Primary fibrinolysis during supraceliac aortic clamping." Journal of vascular surgery.. 1997 Feb 0; 25(2):244-51; discussion 252-4.

1/1997
Francis CW, Felcher AH, White J, Braaten JV, Goss R. "Thrombin activity associated with indwelling central venous catheters." Thrombosis and haemostasis.. 1997 Jan 0; 77(1):48-52.

1997
Braaten JV; Goss RA; Francis CW. "Ultrasound reversibly disaggregates fibrin fibers". Thrombosis Haemost. 1997; 78: 1063-1068.

1997
Everbach EC; Makin IR; Francis CW; et al. "Effect of acoustic cavitation on platelets in the presence of an echo-contrast agent". Ultrasound Med Biol. 1997; 24: 129-136.

1997
Dalecki D, Raeman CH, Child SZ, Cox C, Francis CW, Meltzer RS, Carstensen EL. "Hemolysis in vivo from exposure to pulsed ultrasound." Ultrasound in medicine & biology.. 1997 23(2):307-13.

12/1996
Odrljin TM, Francis CW, Sporn LA, Bunce LA, Marder VJ, Simpson-Haidaris PJ. "Heparin-binding domain of fibrin mediates its binding to endothelial cells." Arteriosclerosis, thrombosis, and vascular biology.. 1996 Dec 0; 16(12):1544-51.

11/14/1996
Odrljin TM, Rybarczyk BJ, Francis CW, Lawrence SO, Hamaguchi M, Simpson-Haidaris PJ. "Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain." Biochimica et biophysica acta.. 1996 Nov 14; 1298(1):69-77.

10/1996
Blinc A, Francis CW. "Transport processes in fibrinolysis and fibrinolytic therapy." Thrombosis and haemostasis.. 1996 Oct 0; 76(4):481-91.

5/1996
Francis CW, Pellegrini VD, Leibert KM, Totterman S, Azodo MV, Harris CM, Cox C, Marder VJ. "Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement." Thrombosis and haemostasis.. 1996 May 0; 75(5):706-11.

1996
Odrljin TM; Francis CW; Sporn LA; et al. "Heparin binding domain of fibrin mediates its binding to endothelial cells". Arterioscl Thrombosis & Vasc Biol. 1996; 16: 1544-1551.

9/1/1995
Sporn LA, Bunce LA, Francis CW. "Cell proliferation on fibrin: modulation by fibrinopeptide cleavage." Blood.. 1995 Sep 1; 86(5):1802-10.

3/1995
Francis CW, Totterman S. "Magnetic resonance imaging of deep vein thrombi correlates with response to thrombolytic therapy." Thrombosis and haemostasis.. 1995 Mar 0; 73(3):386-91.

3/1995
Siddiqi F, Blinc A, Braaten J, Francis CW. "Ultrasound increases flow through fibrin gels." Thrombosis and haemostasis.. 1995 Mar 0; 73(3):495-8.

1995
Francis CW, Blinc A, Lee S, Cox C. "Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots." Ultrasound in medicine & biology.. 1995 21(3):419-24.

12/1/1994
Kashyap A, Blinc A, Marder VJ, Penney DP, Francis CW. "Acceleration of fibrinolysis by ultrasound in a rabbit ear model of small vessel injury." Thrombosis research.. 1994 Dec 1; 76(5):475-85.

11/1994
Shammas NW, Cunningham MJ, Pomerantz RM, Francis CW. "Markers of hemostatic activation in affected coronary arteries during angioplasty." Thrombosis and haemostasis.. 1994 Nov 0; 72(5):672-5.

8/15/1994
Hamaguchi M, Bunce LA, Sporn LA, Francis CW. "Plasmic degradation of fibrin rapidly decreases platelet adhesion and spreading." Blood.. 1994 Aug 15; 84(4):1143-50.

6/1994
Sham RL, Francis CW. "Evaluation of mild bleeding disorders and easy bruising." Blood reviews.. 1994 Jun 0; 8(2):98-104.

6/1994
Ouriel K, Shortell CK, DeWeese JA, Green RM, Francis CW, Azodo MV, Gutierrez OH, Manzione JV, Cox C, Marder VJ. "A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia." Journal of vascular surgery.. 1994 Jun 0; 19(6):1021-30.

5/1994
Harpaz D, Chen X, Francis CW, Meltzer RS. "Ultrasound accelerates urokinase-induced thrombolysis and reperfusion." American heart journal.. 1994 May 0; 127(5):1211-9.

3/1994
Blombäck M, Abildgaard U, van den Besselaar AM, Clementson KJ, Dahlbäck B, Exner T, Francis CW, Gaffney P, Gralnick H, Hoyer LW. "Nomenclature of quantities and units in thrombosis and haemostasis (recommendation 1993). A Collaborative project of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (ISTH/SSC) and the Commission/Committee on Quantities and Units (in Clinical Chemistry) of the International Union of Pure and Applied Chemistry-International Federation of Clinical Chemistry (IUPAC-IFCC/CQU(CC))." Thrombosis and haemostasis.. 1994 Mar 0; 71(3):375-94.

2/1994
Blinc A, Kennedy SD, Bryant RG, Marder VJ, Francis CW. "Flow through clots determines the rate and pattern of fibrinolysis." Thrombosis and haemostasis.. 1994 Feb 0; 71(2):230-5.

1994
Blinc A; Francis CW; Kennedy SD; et al. "Flow through clots determines the rate and pattern of fibrinolysis". Thrombo Haemost. 1994; 71: 230-235.

1994
Onundarson PT; Haraldsson HM; Bermann L; Francis CW; et al. "Onundarson PT; Haraldsson HM; Bermann L; Francis CW; et al". Thromb Haemost. 1994; 70: 998-1004.

12/20/1993
Onundarson PT, Haraldsson HM, Bergmann L, Francis CW, Marder VJ. "Plasminogen depletion during streptokinase treatment or two-chain urokinase incubation correlates with decreased clot lysability ex vivo and in vitro." Thrombosis and haemostasis.. 1993 Dec 20; 70(6):998-1004.

12/15/1993
Weisel JW, Francis CW, Nagaswami C, Marder VJ. "Determination of the topology of factor XIIIa-induced fibrin gamma-chain cross-links by electron microscopy of ligated fragments." The Journal of biological chemistry.. 1993 Dec 15; 268(35):26618-24.

10/15/1993
Lawrence SO, Wright TW, Francis CW, Fay PJ, Haidaris PJ. "Purification and functional characterization of homodimeric gamma B-gamma B fibrinogen from rat plasma." Blood.. 1993 Oct 15; 82(8):2406-13.

10/1993
Pellegrini VD, Langhans MJ, Totterman S, Marder VJ, Francis CW. "Embolic complications of calf thrombosis following total hip arthroplasty." The Journal of arthroplasty.. 1993 Oct 0; 8(5):449-57.

8/1993
Kornberg A, Francis CW, Pellegrini VD, Gabriel KR, Marder VJ. "Comparison of native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant prophylaxis." Circulation.. 1993 Aug 0; 88(2):454-60.

5/15/1993
Blinc A, Francis CW, Trudnowski JL, Carstensen EL. "Characterization of ultrasound-potentiated fibrinolysis in vitro." Blood.. 1993 May 15; 81(10):2636-43.

5/1/1993
Hamaguchi M, Bunce LA, Sporn LA, Francis CW. "Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15-42." Blood.. 1993 May 1; 81(9):2348-56.

5/1993
Harpaz D, Chen X, Francis CW, Marder VJ, Meltzer RS. "Ultrasound enhancement of thrombolysis and reperfusion in vitro." Journal of the American College of Cardiology.. 1993 May 0; 21(6):1507-11.

2/1993
Dustan HP, Francis CW, Allen HD, Cunningham SL, Dulany W, Hay J, Kaiser GA, Lee TH, Mattson P, Ness DA. "Principles of access to health care. Access to Health Care Task Force, American Heart Association." Circulation.. 1993 Feb 0; 87(2):657-8.

1993
Francis CW, Bunce LA, Sporn LA. "Endothelial cell responses to fibrin mediated by FPB cleavage and the amino terminus of the beta chain." Blood cells. 1993 19(2):291-306; discussion 306-7.

12/4/1992
Francis CW, Kornberg A. "Fibrinogen- and fibrin-degradation products during fibrinolytic therapy." Annals of the New York Academy of Sciences.. 1992 Dec 4; 667:310-23.

11/1992
Francis CW, Onundarson PT, Carstensen EL, Blinc A, Meltzer RS, Schwarz K, Marder VJ. "Enhancement of fibrinolysis in vitro by ultrasound." The Journal of clinical investigation.. 1992 Nov 0; 90(5):2063-8.

8/1/1992
Kornberg A, Francis CW, Marder VJ. "Plasma crosslinked fibrin polymers: quantitation based on tissue plasminogen activator conversion to D-dimer and measurement in normal and patients with acute thrombotic disorders." Blood.. 1992 Aug 1; 80(3):709-17.

7/1992
Onundarson PT, Francis CW, Marder VJ. "Depletion of plasminogen in vitro or during thrombolytic therapy limits fibrinolytic potential." The Journal of laboratory and clinical medicine.. 1992 Jul 0; 120(1):120-8.

6/3/1992
Francis CW, Pellegrini VD, Marder VJ, Totterman S, Harris CM, Gabriel KR, Azodo MV, Leibert KM. "Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement." JAMA.. 1992 Jun 3; 267(21):2911-5.

5/1992
Marder VJ, Brenner B, Totterman S, Francis CW, Rubin R, Rao AK, Kessler CM, Kwaan HC, Sharma GV, Fong KL. "Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis." The Journal of laboratory and clinical medicine.. 1992 May 0; 119(5):485-95.

4/1992
Onundarson PT, Rowe JM, Heal JM, Francis CW. "Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura. A 10-year experience at a single institution." Archives of internal medicine.. 1992 Apr 0; 152(4):791-6.

3/1992
Bunce LA, Sporn LA, Francis CW. "Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain." The Journal of clinical investigation.. 1992 Mar 0; 89(3):842-50.

3/1992
Owens MR, Ribes JA, Marder VJ, Francis CW. "Effects of ionic and nonionic radiographic contrast agents on endothelial cells in vitro." The Journal of laboratory and clinical medicine.. 1992 Mar 0; 119(3):315-9.

1992
Onundarson PT; Rose JM; Heal JM; Francis CW. "Response to plasma exchange and splenectomy in thrombotic thrombocytopenic purpura: a ten year experience at a single institution." Arch Int Med. 1992; 152: 791-796.

1992
Francis CW; Kornberg A. "Fibrinogen and fibrin degradation products during fibrinolytic therapy." Proc New York Acad Sci. 1992; 667: 310-323.

4/1991
Francis CW, Brenner B, Leddy JP, Marder VJ. "Angioedema during therapy with recombinant tissue plasminogen activator." British journal of haematology.. 1991 Apr 0; 77(4):562-3.

1/1991
Francis CW, Pellegrini VD, Harris CM, Stulberg B, Gabriel KR, Marder VJ. "Prophylaxis of venous thrombosis following total hip and total knee replacement using antithrombin III and heparin." Seminars in hematology.. 1991 Jan 0; 28(1):39-45.

1991
Francis CW; Brenner B; Leddy JP; Marder VJ. "Angioedema during therapy with recombinant tissue plasminogen activator". Brit J Hematol. 1991; 77.

1991
Francis CW, Marder VJ. "Fibrinolytic therapy for venous thrombosis." Progress in cardiovascular diseases.. 1991 34(3):193-204.

12/1990
Blackmore CC, Francis CW, Bryant RG, Brenner B, Marder VJ. "Magnetic resonance imaging of blood and clots in vitro." Investigative radiology.. 1990 Dec 0; 25(12):1316-24.

8/1990
Francis CW, Pellegrini VD, Stulberg BN, Miller ML, Totterman S, Marder VJ. "Prevention of venous thrombosis after total knee arthroplasty. Comparison of antithrombin III and low-dose heparin with dextran." The Journal of bone and joint surgery. American volume.. 1990 Aug 0; 72(7):976-82.

6/1990
Brenner B, Francis CW, Totterman S, Kessler CM, Rao AK, Rubin R, Kwaan HC, Gabriel KR, Marder VJ. "Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation." Circulation.. 1990 Jun 0; 81(6):1818-25.

4/1/1990
Ribes JA, Francis CW. "Multimer size dependence of von Willebrand factor binding to crosslinked or noncrosslinked fibrin." Blood.. 1990 Apr 1; 75(7):1460-5.

3/1990
Mehta RL, Scott G, Sloand JA, Francis CW. "Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis." The American journal of medicine.. 1990 Mar 0; 88(3):252-7.

1/1990
Totterman S, Francis CW, Foster TH, Brenner B, Marder VJ, Bryant RG. "Diagnosis of femoropopliteal venous thrombosis with MR imaging: a comparison of four MR pulse sequences." AJR. American journal of roentgenology.. 1990 Jan 0; 154(1):175-8.

1990
Bryant, RG; Marill, K; Blackmore, CC; Francis, CW. "Magnetic relaxation in blood and blood clots". Magnetic Resonance in Med. 1990; 13: 133-144.

1990
Francis, CW; Pellegrini, VD; Stulberg, BN; et al. "Prevention of venous thrombosis following total knee arthroplasty". J Bone & Joint Surg. 1990; 72-A: 976-982.

11/15/1989
Haidaris PJ, Peerschke EI, Marder VJ, Francis CW. "The C-terminal sequences of the gamma 57.5 chain of human fibrinogen constitute a plasmin sensitive epitope that is exposed in crosslinked fibrin." Blood.. 1989 Nov 15; 74(7):2437-44.

11/1989
Stulberg BN, Francis CW, Pellegrini VD, Miller ML, Shull S, deSwart R, Easley K, Totterman S, Marder VJ. "Antithrombin III/low-dose heparin in the prevention of deep-vein thrombosis after total knee arthroplasty. A preliminary report." Clinical orthopaedics and related research.. 1989 Nov 0; (248):152-7.

9/29/1989
Francis CW, Mosesson MW. "Terminology for fibrinogen gamma-chains differing in carboxyl terminal amino acid sequence." Thrombosis and haemostasis.. 1989 Sep 29; 62(2):813-4.

9/11/1989
Francis CW, Pellegrini VD, Harris CM, Marder VJ. "Antithrombin III prophylaxis of venous thromboembolic disease after total hip or total knee replacement." The American journal of medicine.. 1989 Sep 11; 87(3B):61S-66S.

8/1/1989
Haidaris PJ, Francis CW, Sporn LA, Arvan DS, Collichio FA, Marder VJ. "Megakaryocyte and hepatocyte origins of human fibrinogen biosynthesis exhibit hepatocyte-specific expression of gamma chain-variant polypeptides." Blood.. 1989 Aug 1; 74(2):743-50.

8/1989
Ribes JA, Ni F, Wagner DD, Francis CW. "Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain." The Journal of clinical investigation.. 1989 Aug 0; 84(2):435-42.

6/1989
Brenner B, Francis CW, Marder VJ. "The role of soluble cross-linked fibrin in D dimer immunoreactivity of plasmic digests." The Journal of laboratory and clinical medicine.. 1989 Jun 0; 113(6):682-8.

5/15/1989
Brenner B, Francis CW, Fitzpatrick PG, Rothbard RL, Cox C, Hackworthy RA, Anderson JL, Sorensen SG, Marder VJ. "Relation of plasma D-dimer concentrations to coronary artery reperfusion before and after thrombolytic treatment in patients with acute myocardial infarction." The American journal of cardiology.. 1989 May 15; 63(17):1179-84.

3/1989
Francis CW, Doughney K, Brenner B, Klingbiel K, Marder VJ. "Increased immunoreactivity of plasma after fibrinolytic activation in an anti-DD ELISA system. Role of soluble crosslinked fibrin polymers." Circulation.. 1989 Mar 0; 79(3):666-73.

3/1989
Francis CW, Pellegrini VD, Marder VJ, Harris CM, Totterman S, Gabriel KR, Baughman DJ, Roemer S, Burke J, Goodman TL. "Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40." The Journal of bone and joint surgery. American volume.. 1989 Mar 0; 71(3):327-35.

1989
Francis, CW; Foster, TH; Totterman, S; et al. "Monitoring of therapy for deep vein thrombosis using magnetic resonance imaging". Acta Radiologica. 1989; 4: 445-446.

1989
Stulberg, BN; Francis, CW; Pellegrini, VD; et al. "Antithrombin III/low dose heparin in the prevention of deep-vein thrombosis following total knee arthroplasty". Clin Ortho Rel Res. 1989; 248: 152-157.

1989
Francis CW, Foster TH, Totterman S, Brenner B, Marder VJ, Bryant RG. "Monitoring of therapy for deep vein thrombosis using magnetic resonance imaging." Acta radiologica.. 1989 30(4):445-6.

7/1988
Francis CW, Ricotta JJ, Evarts CM, Marder VJ. "Long-term clinical observations and venous functional abnormalities after asymptomatic venous thrombosis following total hip or knee arthroplasty." Clinical orthopaedics and related research.. 1988 Jul 0; (232):271-8.

5/1988
Francis CW, Marder VJ. "Increased resistance to plasmic degradation of fibrin with highly crosslinked alpha-polymer chains formed at high factor XIII concentrations." Blood.. 1988 May 0; 71(5):1361-5.

5/1988
Francis CW, Müller E, Henschen A, Simpson PJ, Marder VJ. "Carboxyl-terminal amino acid sequences of two variant forms of the gamma chain of human plasma fibrinogen." Proceedings of the National Academy of Sciences of the United States of America.. 1988 May 0; 85(10):3358-62.

2/1988
Woodlock TJ, Francis CW, Rowe JM, Brown MJ, Marder VJ. "Prolonged remission after life-threatening gastrointestinal hemorrhage from coexistent angiodysplasia and acquired bleeding diathesis." American journal of hematology.. 1988 Feb 0; 27(2):125-31.

1988
Francis, CW; Ricotta, JJ; Evarts, CM; Marder, VJ. "Long term clinical findings and venous functional abnormalities after asymptomatic total hip and knee replacement". Clin Orth Rel Res. 1988; 232: 271-278.

11/1987
Francis CW, Marder VJ. "Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII." The Journal of clinical investigation.. 1987 Nov 0; 80(5):1459-65.

6/1987
Francis CW, Connaghan DG, Scott WL, Marder VJ. "Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction." Circulation.. 1987 Jun 0; 75(6):1170-7.

3/1987
Francis CW, Marder VJ. "Physiologic regulation and pathologic disorders of fibrinolysis." Human pathology.. 1987 Mar 0; 18(3):263-74.

2/3/1987
Francis CW, Alkjaersig N, Galanakis DK, Graeff H, Owen J, Gaffney P, Marder VJ. "Terminology for macromolecular plasmic derivatives of crosslinked fibrin." Thrombosis and haemostasis.. 1987 Feb 3; 57(1):110-1.

1/1987
Ribes JA, Francis CW, Wagner DD. "Fibrin induces release of von Willebrand factor from endothelial cells." The Journal of clinical investigation.. 1987 Jan 0; 79(1):117-23.

1987
Marder, VJ; Francis, CW. "Two-step warfarin therapy for the prophylaxis of venous thrombosis after elective surgery". Avd Exp Med Biol. 1987; 214: 159-163.

1987
Marder VJ, Rothbard RL, Fitzpatrick PG, Francis CW, Norry EC. "Dose-ranging studies of anisoylated plasminogen streptokinase activator complex. Studies in healthy volunteers and in patients with acute myocardial infarction." Drugs.. 1987 33 Suppl 3:124-32.

1987
Marder VJ, Francis CW. "Physiological balance of haemostasis and bleeding." Drugs.. 1987 33 Suppl 3:13-21.

1987
Mader VJ, Francis CW. "Two-step warfarin therapy for the prophylaxis of venous thrombosis after elective surgery." Advances in experimental medicine and biology.. 1987 214:159-63.

11/1986
Francis CW, Connaghan DG, Marder VJ. "Assessment of fibrin degradation products during fibrinolytic therapy for acute myocardial infarction." Circulation.. 1986 Nov 0; 74(5):1027-36.

9/1986
Connaghan DG, Francis CW, Ryan DH, Marder VJ. "Prevalence and clinical implications of heparin-associated false positive tests for serum fibrin(ogen) degradation products." American journal of clinical pathology.. 1986 Sep 0; 86(3):304-10.

6/1986
Scott WL, Francis CW, Knutson DW, Marder VJ. "Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation." The Journal of laboratory and clinical medicine.. 1986 Jun 0; 107(6):534-43.

4/5/1986
Francis CW, Marder VJ, Evarts CM. "Lower risk of thromboembolic disease after total hip replacement with non-cemented than with cemented prostheses." Lancet.. 1986 Apr 5; 1(8484):769-71.

4/1986
Francis CW, Marder VJ. "Degradation of cross-linked fibrin by human leukocyte proteases." The Journal of laboratory and clinical medicine.. 1986 Apr 0; 107(4):342-52.

3/1986
Marder VJ, Rothbard RL, Fitzpatrick PG, Francis CW. "Rapid lysis of coronary artery thrombi with anisoylated plasminogen: streptokinase activator complex. Treatment by bolus intravenous injection." Annals of internal medicine.. 1986 Mar 0; 104(3):304-10.

2/1986
Peerschke EI, Francis CW, Marder VJ. "Fibrinogen binding to human blood platelets: effect of gamma chain carboxyterminal structure and length." Blood.. 1986 Feb 0; 67(2):385-90.

1986
Francis, CW; Marder, VJ. "Degradation of crosslinked fibrin by human leukocyte proteases". J Lab Clin Med. 1986; 107.

1986
Francis CW, Marder VJ. "Concepts of clot lysis." Annual review of medicine.. 1986 37:187-204.

12/1985
Francis CW, Malone JE, Marder VJ. "Comparison of a chromogenic prothrombin time with clotting prothrombin time in the assessment of clinical coagulation deficiencies." American journal of clinical pathology.. 1985 Dec 0; 84(6):724-9.

10/1985
Rowe JM, Francis CW, Cyran EM, Marder VJ. "Thrombotic thrombocytopenic purpura: recovery after splenectomy associated with persistence of abnormally large von Willebrand factor multimers." American journal of hematology.. 1985 Oct 0; 20(2):161-8.

3/1985
Connaghan DG, Francis CW, Lane DA, Marder VJ. "Specific identification of fibrin polymers, fibrinogen degradation products, and crosslinked fibrin degradation products in plasma and serum with a new sensitive technique." Blood.. 1985 Mar 0; 65(3):589-97.

3/1985
Rothbard RL, Fitzpatrick PG, Francis CW, Caton DM, Hood WB, Marder VJ. "Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase." Circulation.. 1985 Mar 0; 71(3):562-70.

11/1984
Marder VJ, Francis CW. "Thrombolytic therapy for acute transmural myocardial infarction. Intracoronary versus intravenous." The American journal of medicine.. 1984 Nov 0; 77(5):921-8.

9/25/1984
Hanna LS, Scheraga HA, Francis CW, Marder VJ. "Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides." Biochemistry.. 1984 Sep 25; 23(20):4681-7.

5/1984
Francis CW, Markham RE, Marder VJ. "Demonstration of in situ fibrin degradation in pathologic thrombi." Blood.. 1984 May 0; 63(5):1216-24.

3/1/1984
Francis CW, Keele EM, Marder VJ. "Purification of three gamma-chains with different molecular weights from normal human plasma fibrinogen." Biochimica et biophysica acta.. 1984 Mar 1; 797(3):328-35.

2/28/1984
Francis CW, Nachman RL, Marder VJ. "Plasma and platelet fibrinogen differ in gamma chain content." Thrombosis and haemostasis.. 1984 Feb 28; 51(1):84-8.

1984
Marder VJ, Francis CW. "An assessment of regional versus systemic thrombolytic treatment of peripheral and coronary artery thrombosis." Progress in hemostasis and thrombosis. 1984 7:325-56.

8/1/1983
Martin SE, Francis CW, Marder VJ. "Potentiation of wheat germ agglutinin aggregation of platelets by von Willebrand protein and by a 116,000 molecular weight tryptic fragment." Thrombosis research.. 1983 Aug 1; 31(3):437-49.

8/1983
Francis CW, Markham RE, Barlow GH, Florack TM, Dobrzynski DM, Marder VJ. "Thrombin activity of fibrin thrombi and soluble plasmic derivatives." The Journal of laboratory and clinical medicine.. 1983 Aug 0; 102(2):220-30.

6/27/1983
Marder VJ, Francis CW. "Plasmin degradation of cross-linked fibrin." Annals of the New York Academy of Sciences.. 1983 Jun 27; 408:397-406.

6/27/1983
Francis CW, Marder VJ. "Heterogeneity of normal human fibrinogen due to two high molecular weight variant gamma chains." Annals of the New York Academy of Sciences.. 1983 Jun 27; 408:118-20.

4/28/1983
Francis CW, Kraus DH, Marder VJ. "Structural and chromatographic heterogeneity of normal plasma fibrinogen associated with the presence of three gamma-chain types with distinct molecular weights." Biochimica et biophysica acta.. 1983 Apr 28; 744(2):155-64.

1/21/1983
Francis CW, Marder VJ, Evarts CM, Yaukoolbodi S. "Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding." JAMA.. 1983 Jan 21; 249(3):374-8.

1983
Martin, SE; Francis, CW; Marder, VJ. "Potentiation of wheat germ aggultinin aggregation of platelets by von Willebrand protein and by a 116,000 molecular weight tryptic fragment". Thromb Res. 1983; 31: 437-449.

12/1982
Barlow GH, Brennan JK, Abboud CN, Francis CW, Lichtman AH, Lichtman MA. "Secretion of plasminogen activator by the human macrophage-like cell line, GCT: separation from colony-stimulating and erythropoiesis-enhancing activities." British journal of haematology.. 1982 Dec 0; 52(4):645-55.

1/1982
Francis CW, Marder VJ. "A molecular model of plasmic degradation of crosslinked fibrin." Seminars in thrombosis and hemostasis.. 1982 Jan 0; 8(1):25-35.

9/15/1981
Barlow GH, Francis CW, Marder VJ. "On the conversion of high molecular weight urokinase to the low molecular weight form by plasmin." Thrombosis research.. 1981 Sep 15; 23(6):541-7.

2/1981
Martin SE, Marder VJ, Francis CW, Barlow GH. "Structural studies of the functional heterogeneity of von Willebrand protein polymers." Blood.. 1981 Feb 0; 57(2):313-23.

1981
Francis, CW; Marder, VJ. "A molecular model of plasmic degradation of crosslinked fibrin". Sem Thromb Haemost. 1981; : 25-35.

11/1980
Francis CW, Marder VJ, Barlow GH. "Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure." The Journal of clinical investigation.. 1980 Nov 0; 66(5):1033-43.

9/1980
Francis CW, Marder VJ, Martin SE. "Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complexes." Blood.. 1980 Sep 0; 56(3):456-64.

6/25/1980
Francis CW, Marder VJ, Martin SE. "Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen." The Journal of biological chemistry.. 1980 Jun 25; 255(12):5599-604.

5/1980
Martin SE, Marder VJ, Francis CW, Loftus LS, Barlow GH. "Enzymatic degradation of the factor-VIII-von-Willebrand protein: a unique tryptic fragment with ristocetin cofactor activity." Blood.. 1980 May 0; 55(5):848-58.

12/1979
Francis CW, Marder VJ, Martin SE. "Detection of circulating crosslinked fibrin derivatives by a heat extraction-SDS gradient gel electrophoretic technique." Blood.. 1979 Dec 0; 54(6):1282-95.

3/30/1979
Bondietti EA, Francis CW. "Geologic migration potentials of technetium-99 and neptunium-237." Science.. 1979 Mar 30; 203(4387):1337-40.

5/1978
Delaney MS, Francis CW. "The relative uptake of 237Pu(IV) and Pu(VI) oxidation states from water by bush beans." Health physics.. 1978 May 0; 34(5):492-4.

1976
Van Hook RI, Blaylock BG, Bondietti EA, Francis CW, Huckabee JW, Reichle DE, Sweeton FH, Witherspoon JP. "Radioisotope techniques in delineation of the environmental behavior of cadmium." Environmental quality and safety. 1976 5:167-82.

12/24/1965
Berger KC, Erhardt WH, Francis CW. "Polonium-210 analyses of vegetables, cured and uncured tobacco, and associated soils." Science.. 1965 Dec 24; 150(3704):1738-9.

0
Colwell CW; Berkowitz SD; Davidson BL; Lotke PA; Ginsberg JS; Francis CW. "Comparison of ximelegatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement." J Thromb Hemost. .

0
Khorana AA; Sahni A; Altland OD; Francis CW. "Heparin inhhibition of endothelial cell proliferation and organization is dependent on nolecular weight". Arterioscler Thromb Vasc Biol. .

0
Peng H; Sahni A; Fay P; Bellum S; Prudosky I; Maciag T; Francis CW. "Identification of a binding site on human FGF-2 for fibrinogen". Blood. .

0
Francis CW; Berkowitz SD; Comp PC. "Comparison of the Oral Direct Thrombin Inhibitor Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism Following Total Knee Replacement: EXULT A. N." N. Eng. J. Med. .

0
Altand OD; Dalecki D; Suchkova VN; Francis CW. "Low-intensity ultrasound increases endothelial cell nitric oxide synthase activity and nitric oxide synthase activity and nitric oxide synthesis". J Thromb Haemost. .

0
Kaba NK; Francis CW; Moss AJ; Zareba W; Oakes D; Knox KL; Fernandez ID; et al. "Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction". J Thromb Haemost. .

0
Joshi SG; Francis CW; Silverman DJ; Sahni SK. "NF-kB activation suppresses host cell apoptosis during Rickettsia rickettsii infection via regulatory effects on intracellular localization or levels of apoptogenic and antiapoptotic proteins." FEMS Microbiology Letters. .

0
Sahni A; Guo M; Sahni SK; Francis CW. "Interluekin-1B but not IL-1a Binds t Fibrinogen and Fibrin and has Enhanced Activity in the Bound form." Blood. .

0
Moss AJ; Ryan D; Oakes D; Goldstein RE; Greenberg H; Bodenheimer MM; Brown MW; Case RB; Francis CW; et al. "Coronary disease-related risk genotypes and reduction in recurrent coronary events after myocardial infarction". JACC. .

0
Komrokji RS; Uppal NP; Khorana AA; Lyman GH; Kaplan KK; Fisher RI; Francis CW. "Venous thromboembolism in patients with diffuse large B cell lymphoma". Leukemia and Lymphoma. .

0
O'Brien JJ; Baglole CJ; Garcia-Bates TM; Blumberg N; Francis CW, Phipps RP. "15-deoxy-(delta)12, 14 prostaglandin J2-induced heme oxygenase-1 in megakaryocytes regulates thrombopoiesis". Thromb Haemost. .

0
. "Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.".

0
C.. Francis. "Treatment of Venous Thromboembolism in cancer patients with dalteparin for up to twelve months. The Daltecan Study". JTH. .

0
Nigel S. Key, Alok A. Khorana, Nigel Mackman, Owen J.T. McCarty, Gilbert C. White, Charles W. Francis, Keith R. McCrae, Joseph S. Palumbo, Gary E. Raskob, Andrew T. Chan, Anil K. Sood. ""Thrombosis in Cancer: Research Priorities Identified by a National Cancer Institute/National Heart, Lung, and Blood Institute Strategic Working Group"". Cancer Research – submitted November 2015. .

Books & Chapters

2006
Chapter Title: Venous and arterial thrombosis
Book Title: Clinical Hematology
Author List: Francis CW; Kaplan K
Published By: MOSBY Elsevier2006

2006
Chapter Title: Clinical disorders of fibrinolysis
Book Title: Hemostasis and Thrombosis: Basic Prin. & Clinical Prac.
Author List: Francis CW; Marder VJ
Published By: Lippincott Wlliams & Wilkins2006

2005
Chapter Title: Physiologic regulation and patholoogic disorders of fibrinolysis
Book Title: Hemostasis & Thrombosis: Basic Prin. & Clin. Prac.
Author List: Francis CW; Marder VJ
Published By: Lippincott Williams & Wilkens2005

2005
Chapter Title: Principles of Anticoagulant Therapy
Book Title: Williams Hematology 7th Ed.
Author List: Francis CW; Kaplan K
Published By: McGraw Hill2005

2005
Chapter Title: Fibrinolysis and Thrombolysis
Book Title: Williams Hematology
Author List: Hajjar KA; Francis CW
Published By: McGraw Hill2005

2005
Chapter Title: Who's at risk for VTE? Strategies for risk stratifying cancer patients.
Book Title: New Findings in Cancer-associated Thrombosis
Author List: Rao, MN; Francis, CW; Khorana, AA.
Published By: Informa Healthcare2005

2004
Chapter Title: Ximelagatran: a new oral anticoagulant
Book Title: Best Practice & Research Clinical Hematology
Author List: Francis CW
Published By: Elsevier Ltd.2004

2003
Chapter Title: Thrombolysis and Ultrasound
Book Title: New Therapeutic Agents in Thrombosis and Thrombolysis
Author List: Francis CW; Suchkova VN
Published By: Marcel Dekker, Inc.2003

2003
Chapter Title: Prevention and Treatment of Venous Thromboembolic Disease
Book Title: Thrombosis and Hemorrhage
Author List: Francis CW
Published By: Lippincott Williams & Wilkins2003

2001
Book Title: Hemostasis and Thrombosis: Basic Principles and Clin. Prac.
Author List: Hantgan RR; Simpson-Haidaris PJ; Francis CW; et al
Published By: Lippincott-Raven2001

2001
Chapter Title: Physiologic regulation and pathologic disorders of fibrinolysis
Book Title: Hemostasis and Thrombosis: Basic Princ. and Clin. Prac.
Author List: Francis CW; Marder VJ
Published By: Lippincott-Raven2001

1995
Chapter Title: The fibrinolytic system: Physiology and Pathophysiology
Book Title: Thrombolytic Therapy for Peripheral Vascular Disease
Author List: Francis CW
Published By: J. B. Lippincott1995

1995
Chapter Title: Hematology problems in the surgical patient: Bleeding and Thrombosis
Book Title: Hematology: Basic Principles and Practice, 2nd ed.
Author List: Francis CW
Published By: Churchill Livingstone1995

1991
Chapter Title: Hematologic problems in the surgical patient: Bleeding and Thrombosis
Book Title: Hematology. Basic principles and Practice
Author List: Francis CW
Published By: Churchill Livingstone1991

1987
Chapter Title: Fibrinogen structure and physiology
Book Title: Hemostasis and Thrombosis
Author List: Hantgan RR; Francis CW; et al
Published By: J. B. Lippincott1987

1987
Chapter Title: Consumptive thrombohemorrhagic disorders
Book Title: Hemostasis and Thrombosis
Author List: Marder VJ; Martin SE; Francis CW; et al
Published By: J. B. Lippincott1987

1982
Chapter Title: Fibrinogen structure and physiology
Book Title: Hemostasis and Thrombosis: Basic principles and clinical prac
Author List: Marder VJ; Francis CW; Doolittle RF
Published By: JB Lippincott Co.1982